LitCovid-sentences  

PMC:7274970 / 14700-18718 JSONTXT 10 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T94 0-117 Sentence denotes 3.2 Demographic and baseline characteristics, as well as laboratory parameters upon hospital admission and treatment
T95 118-220 Sentence denotes The median age of patients was 63 years (IQR, 55–69 years), and 57.8% of patients were men (Table 1 ).
T96 221-313 Sentence denotes The median interval time from symptom onset to admission was 11.0 days (IQR, 9.0–13.5 days).
T97 314-487 Sentence denotes A total of 83 (61.5%) patients had comorbidities, and 134 (99.3%) patients had bilateral distribution of patchy shadows or ground glass opacity on chest x-ray or CT imaging.
T98 488-699 Sentence denotes There were no significant between-group differences in demographic and baseline characteristics (Table 1), as well as laboratory parameters upon hospital admission and treatment during hospitalization (Table 3).
T99 700-776 Sentence denotes Table 1 Demographics and baseline characteristics of patients with COVID-19.
T100 777-840 Sentence denotes Total (n = 135) Good sleep (n = 60) Poor sleep (n = 75) P value
T101 841-905 Sentence denotes Age, median (IQR), years 63 (55–69) 61 (51–68) 64 (56–70) 0.1126
T102 906-953 Sentence denotes  < 50 years 22 (16.3) 14 (23.3) 9 (12.0) 0.0818
T103 954-1003 Sentence denotes  50–70 years 83 (61.5) 36 (60.0) 46 (61.3) 0.8747
T104 1004-1052 Sentence denotes  ≥ 70 years 30 (22.2) 10 (16.7) 20 (26.7) 0.1649
T105 1053-1057 Sentence denotes Sex:
T106 1058-1100 Sentence denotes  Male 78 (57.8) 40 (66.7) 38 (50.7) 0.0614
T107 1101-1138 Sentence denotes  Female 57 (42.2) 20 (33.3) 37 (49.3)
T108 1139-1221 Sentence denotes BMI, median (IQR), kg/m2 23.9 (22.3–25.6) 23.8 (22.5–25.3) 24.2 (22.0–25.7) 0.7886
T109 1222-1237 Sentence denotes Marital status:
T110 1238-1284 Sentence denotes  Married 129 (95.6) 57 (95.0) 72 (96.0) 0.7794
T111 1285-1326 Sentence denotes  Unmarried 3 (2.2) 2 (3.3) 1 (1.3) 0.8447
T112 1327-1376 Sentence denotes  Death of a spouse 3 (2.2) 1 (1.7) 2 (2.7) 0.8447
T113 1377-1393 Sentence denotes Education level:
T114 1394-1445 Sentence denotes  ≤ High school 96 (71.1) 39 (65.0) 57 (76.0) 0.1612
T115 1446-1505 Sentence denotes  University or college 32 (23.7) 17 (28.3) 15 (20.0) 0.2579
T116 1506-1554 Sentence denotes  Master or doctor 7 (5.2) 4 (6.7) 3 (4.0) 0.4875
T117 1555-1599 Sentence denotes Current smoking 4 (3.0) 0 (0) 4 (5.3) 0.1918
T118 1600-1614 Sentence denotes Comorbidities:
T119 1615-1651 Sentence denotes 83 (61.5) 34 (56.7) 49 (65.3) 0.3038
T120 1652-1733 Sentence denotes  Cardiovascular and cerebrovascular diseases 42 (31.1) 19 (31.7) 23 (30.7) 0.9008
T121 1734-1789 Sentence denotes  Endocrine disease 38 (28.1) 16 (26.7) 22 (29.3) 0.7321
T122 1790-1834 Sentence denotes  Malignancy 13 (9.6) 4 (6.7) 9 (12.0) 0.2966
T123 1835-1894 Sentence denotes  Chronic respiratory disease 6 (4.4) 1 (1.7) 5 (6.7) 0.3268
T124 1895-1951 Sentence denotes  Gastrointestinal disease 4 (3.0) 1 (1.7) 3 (4.0) 0.7766
T125 1952-1999 Sentence denotes  Urologic diseases 2 (1.5) 0 (0) 2 (2.7) 0.5025
T126 2000-2113 Sentence denotes Onset of symptom to hospital admission, median (IQR), days 11.0 (9.0–13.5) 11.0 (9.0–15.0) 11.0 (8.5–13.0) 0.5954
T127 2114-2150 Sentence denotes Signs and symptoms at disease onset:
T128 2151-2195 Sentence denotes  Fever 123 (91.1) 53 (88.3) 70 (93.3) 0.3104
T129 2196-2239 Sentence denotes  Cough 92 (68.1) 38 (63.3) 54 (72.0) 0.2828
T130 2240-2297 Sentence denotes  Shortness of breath 75 (55.6) 31 (51.7) 44 (58.7) 0.4160
T131 2298-2343 Sentence denotes  Fatigue 68 (50.4) 32 (53.3) 36 (48.0) 0.5380
T132 2344-2395 Sentence denotes  Expectoration 37 (27.4) 14 (23.3) 23 (30.7) 0.3425
T133 2396-2455 Sentence denotes  Myalgia or arthralgia 34 (25.2) 15 (25.0) 19 (25.3) 0.9646
T134 2456-2502 Sentence denotes  Diarrhoea 18 (13.3) 7 (11.7) 11 (14.7) 0.6104
T135 2503-2548 Sentence denotes  Chills 18 (13.3) 8 (13.3) 10 (13.3) > 0.9999
T136 2549-2602 Sentence denotes  Nausea or Vomiting 15 (11.1) 9 (15.0) 6 (8.0) 0.1984
T137 2603-2645 Sentence denotes  Anorexia 12 (8.9) 7 (11.7) 5 (6.7) 0.3104
T138 2646-2687 Sentence denotes  Headache 10 (7.4) 5 (8.3) 5 (6.7) 0.9707
T139 2688-2729 Sentence denotes  Dizziness 5 (3.7) 2 (3.3) 3 (4.0) 0.7989
T140 2730-2772 Sentence denotes  Chest pain 5 (3.7) 2 (3.3) 3 (4.0) 0.7989
T141 2773-2815 Sentence denotes  Pharyngalgia 3 (2.2) 3 (5.0) 0 (0) 0.1704
T142 2816-2861 Sentence denotes  Rhinorrhoea 2 (1.5) 1 (1.7) 1 (1.3) > 0.9999
T143 2862-2903 Sentence denotes  Haemoptysis 2 (1.5) 2 (3.3) 0 (0) 0.1957
T144 2904-2948 Sentence denotes  Abdominal pain 2 (1.5) 2 (3.3) 0 (0) 0.1957
T145 2949-2974 Sentence denotes Vital signs on admission:
T146 2975-3066 Sentence denotes  Body tempreture, median (IQR), ℃ 36.9 (36.5–38.0) 36.9 (36.6–38.0) 36.8 (36.5–37.9) 0.4967
T147 3067-3172 Sentence denotes  Systolic pressure, median (IQR), mmHg 131.0 (120.0–143.0) 131.5 (117.5–145.0) 131.0 (120.0–142.5) 0.5040
T148 3173-3275 Sentence denotes  Heart rate, median (IQR), beat per minute 85.0 (75.5–100.0) 80.5 (74.5–99.0) 87.0 (77.5–100.5) 0.2444
T149 3276-3385 Sentence denotes  Respiratory rate, median (IQR), breaths per minute 20.0 (20.0–24.5) 20.0 (20.0–24.0) 21.0 (20.0–25.0) 0.2136
T150 3386-3475 Sentence denotes  Percutaneous oxygen saturation, median (IQR), %† 95 (92–96) 95 (91–96) 94 (92–96) 0.9816
T151 3476-3570 Sentence denotes Bilateral distribution of patchy shadows or ground glass opacity on chest x-ray or CT imaging:
T152 3571-3608 Sentence denotes 134 (99.3) 59 (98.3) 75 (100%) 0.2618
T153 3609-3666 Sentence denotes Values are numbers (percentages) unless stated otherwise.
T154 3667-3718 Sentence denotes Abbreviations: IQR, interquartile range; n, number.
T155 3719-3792 Sentence denotes P values indicate differences between good-sleep and poor-sleep patients.
T156 3793-3843 Sentence denotes P < 0.05 was considered statistically significant.
T157 3844-4018 Sentence denotes †Data were missing for the measurement of percutaneous oxygen saturation in eight patients (13.3%) of the good-sleep group, and nine patients (12.0%) of the poor-sleep group.